Headquartered in New York, BeyondSpring Inc. (BeyondSpring) is a global, clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from collaboration with University of Washington in de novo drug discovery using a ubiquitination platform. BeyondSpring's lead asset, Plinabulin, is in two Phase 3 global clinical trial as a direct anticanc...
Headquartered in New York, BeyondSpring Inc. (BeyondSpring) is a global, clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from collaboration with University of Washington in de novo drug discovery using a ubiquitination platform. BeyondSpring's lead asset, Plinabulin, is in two Phase 3 global clinical trial as a direct anticancer agent in the treatment of non-small cell lung cancer (NSCLC) and in the prevention of chemotherapy-induced neutropenia (CIN).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.